Rykindo

Shandong Luye Pharmaceutical Co., Ltd.🇺🇸 United States

FDA Page

Effective Date: May 26, 2026
Approval ID: 58534c96-96f5-4c2e-a061-92d4506aee91
Products: 4 registered
Version: 10

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use RYKINDO safely and effectively. See full prescribing information for RYKINDO. RYKINDO (risperidone) for extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 1993

Quick Stats

Total Products4

Labelers2

Label Sections32

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.